Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer.

Miyoshi Y, Sakamoto S, Kawahara T, Uemura K, Yokomizo Y, Uemura H.

Urol Int. 2019;103(3):279-284. doi: 10.1159/000502655. Epub 2019 Aug 28.

PMID:
31461725
2.

Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naïve Prostate Cancer.

Miyoshi Y, Ohtaka M, Kawahara T, Ohtake S, Yasui M, Uemura K, Yoneyama S, Yokomizo Y, Uemura H, Miyamoto H, Yao M.

Urol Int. 2019;102(1):37-42. doi: 10.1159/000493324. Epub 2018 Oct 16.

PMID:
30326476
3.

Laparoscopic treatment of a vesicointestinal fistula due to a Meckel's diverticulum: a case report and review of the literature.

Hakoda H, Mishima H, Habu T, Murai S, Maeno R, Yokomizo Y, Inagaki Y, Maruyama T, Matsui Y, Sako A.

Clin J Gastroenterol. 2018 Dec;11(6):476-480. doi: 10.1007/s12328-018-0878-9. Epub 2018 Jun 18. Review.

PMID:
29915984
4.

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel.

Uemura K, Miyoshi Y, Kawahara T, Ryosuke J, Yamashita D, Yoneyama S, Yokomizo Y, Kobayashi K, Kishida T, Yao M, Uemura H.

BMC Cancer. 2018 May 2;18(1):501. doi: 10.1186/s12885-018-4401-y.

5.

Efficacy and safety of 3-month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study.

Ozono S, Tsukamoto T, Naito S, Horie S, Ohashi Y, Uemura H, Yokomizo Y, Fukasawa S, Kusuoka H, Akazawa R, Saito M, Akaza H.

Cancer Sci. 2018 Jun;109(6):1920-1929. doi: 10.1111/cas.13600. Epub 2018 May 23.

6.

Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy.

Uemura K, Kawahara T, Yamashita D, Jikuya R, Abe K, Tatenuma T, Yokomizo Y, Izumi K, Teranishi JI, Makiyama K, Yumura Y, Kishida T, Udagawa K, Kobayashi K, Miyoshi Y, Yao M, Uemura H.

Biomed Res Int. 2017;2017:7538647. doi: 10.1155/2017/7538647. Epub 2017 Aug 29.

7.

Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes.

Yokomizo Y, Kawahara T, Nagashima Y, Ishiguro H, Kato I, Yao M, Miyamoto H, Uemura H.

Int J Surg Case Rep. 2017;37:180-182. doi: 10.1016/j.ijscr.2017.06.047. Epub 2017 Jun 29. No abstract available.

8.

Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancer.

Ohtaka M, Miyoshi Y, Kawahara T, Ohtake S, Yasui M, Uemura K, Yoneyama S, Hattori Y, Teranishi JI, Yokomizo Y, Uemura H, Miyamoto H, Yao M.

Urol Oncol. 2017 Oct;35(10):607.e9-607.e14. doi: 10.1016/j.urolonc.2017.05.019. Epub 2017 Jun 20.

PMID:
28641939
9.

Prediction of Time to Castration-Resistant Prostate Cancer Using Bone Scan Index in Men with Metastatic Hormone-Sensitive Prostate Cancer.

Miyoshi Y, Yoneyama S, Kawahara T, Hattori Y, Teranishi JI, Ohta JI, Takebayashi S, Yokomizo Y, Hayashi N, Uemura H.

Urol Int. 2017;99(4):400-405. doi: 10.1159/000477131. Epub 2017 Jun 14.

PMID:
28609769
10.

Modified C index: Novel predictor of postoperative renal functional loss of laparoscopic partial nephrectomy.

Ito H, Makiyama K, Kawahara T, Osaka K, Izumi K, Yokomizo Y, Nakaigawa N, Yao M.

Can Urol Assoc J. 2017 May;11(5):E215-E221. doi: 10.5489/cuaj.4192. Epub 2017 May 9.

11.

Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10 ng/ml.

Furuya K, Kawahara T, Narahara M, Tokita T, Fukui S, Imano M, Mitome T, Ito Y, Izumi K, Osaka K, Yokomizo Y, Hayashi N, Hasumi H, Nawata S, Kawano T, Yao M, Uemura H.

Scand J Urol. 2017 Aug;51(4):251-257. doi: 10.1080/21681805.2017.1298155. Epub 2017 Mar 29.

PMID:
28351193
12.

One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.

Ito H, Kondo K, Kawahara T, Kaneta T, Tateishi U, Ueno D, Namura K, Kobayashi K, Miyoshi Y, Yumura Y, Makiyama K, Hayashi N, Hasumi H, Osaka K, Yokomizo Y, Teranishi JI, Hattori Y, Inoue T, Uemura H, Yao M, Nakaigawa N.

Cancer Chemother Pharmacol. 2017 May;79(5):855-861. doi: 10.1007/s00280-017-3275-z. Epub 2017 Mar 22.

PMID:
28331985
13.

Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate.

Miyoshi Y, Uemura K, Kawahara T, Yoneyama S, Hattori Y, Teranishi JI, Ohta JI, Takebayashi S, Yokomizo Y, Hayashi N, Yao M, Uemura H.

Clin Genitourin Cancer. 2017 Aug;15(4):472-478. doi: 10.1016/j.clgc.2016.12.020. Epub 2016 Dec 29.

PMID:
28110835
14.

[A CASE OF XANTHOGRANULOMATOUS PYELONEPHRITIS ASSOCIATED WITH CHROMOPHOBE RENAL CELL CARCINOMA].

Shimbori M, Nakaigawa N, Yokomizo Y, Kasahara R, Sato M, Hasumi H, Hayashi N, Makiyama K, Kondo K, Umeda S, Yao M.

Nihon Hinyokika Gakkai Zasshi. 2017;108(3):154-157. doi: 10.5980/jpnjurol.108.154. Japanese.

15.

[MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA SUCCESFULLY CONTROLED BY TEMISIROLIMUS: A CASE REPORT].

Kasahara R, Nakaigawa N, Yokomizo Y, Hasumi H, Hayashi N, Muraoka K, Takizawa A, Hibiya T, Yamanaka S, Nagashima Y, Yao M.

Nihon Hinyokika Gakkai Zasshi. 2017;108(3):149-153. doi: 10.5980/jpnjurol.108.149. Japanese.

16.

RANK/RANKL expression in prostate cancer.

Ohtaka M, Kawahara T, Mochizuki T, Takamoto D, Hattori Y, Teranishi JI, Miyoshi Y, Yumura Y, Hasumi H, Yokomizo Y, Hayashi N, Kondo K, Yao M, Miyamoto H, Uemura H.

Int J Surg Case Rep. 2017;30:106-107. doi: 10.1016/j.ijscr.2016.11.042. Epub 2016 Nov 29. No abstract available.

17.
18.

Acute aortic occlusion in a patient with chronic paralysis due to spinal cord injury: a case report.

Yamamoto S, Yokomizo Y, Akai T, Chiyoda T, Goto H, Masaki Y.

Surg Case Rep. 2016 Dec;2(1):121. Epub 2016 Nov 2.

19.

Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer.

Yasui M, Uemura K, Yoneyama S, Kawahara T, Hattori Y, Teranishi JI, Inoue M, Ohta JI, Yokomizo Y, Yao M, Uemura H, Miyoshi Y.

Jpn J Clin Oncol. 2016 Aug 17. [Epub ahead of print]

PMID:
27534799
20.

Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade.

Yokomizo Y, Kawahara T, Miyoshi Y, Otani M, Yamanaka S, Teranishi J, Noguchi K, Yao M, Uemura H.

Biomed Res Int. 2016;2016:4083183. doi: 10.1155/2016/4083183. Epub 2016 Jul 14.

21.

Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score.

Kawahara T, Fusayasu S, Izumi K, Yokomizo Y, Ito H, Ito Y, Kurita K, Furuya K, Hasumi H, Hayashi N, Myoshi Y, Miyamoto H, Yao M, Uemura H.

BMC Urol. 2016 Jun 17;16(1):32. doi: 10.1186/s12894-016-0151-9.

22.

Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases.

Miyoshi Y, Yoneyama S, Kawahara T, Hattori Y, Teranishi J, Kondo K, Moriyama M, Takebayashi S, Yokomizo Y, Yao M, Uemura H, Noguchi K.

BMC Cancer. 2016 Feb 19;16:128. doi: 10.1186/s12885-016-2176-6.

23.

Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer.

Kawahara T, Yokomizo Y, Ito Y, Ito H, Ishiguro H, Teranishi J, Makiyama K, Miyoshi Y, Miyamoto H, Yao M, Uemura H.

BMC Cancer. 2016 Feb 16;16:111. doi: 10.1186/s12885-016-2134-3.

24.

Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer.

Uemura K, Miyoshi Y, Kawahara T, Yoneyama S, Hattori Y, Teranishi J, Kondo K, Moriyama M, Takebayashi S, Yokomizo Y, Yao M, Uemura H, Noguchi K.

BMC Cancer. 2016 Feb 16;16:109. doi: 10.1186/s12885-016-2160-1.

25.

Beneficial effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on atopic dermatitis: results of daily intake by adult patients in two open trials.

Harima-Mizusawa N, Kamachi K, Kano M, Nozaki D, Uetake T, Yokomizo Y, Nagino T, Tanaka A, Miyazaki K, Nakamura S.

Biosci Microbiota Food Health. 2016;35(1):29-39. doi: 10.12938/bmfh.2015-010. Epub 2015 Oct 27.

26.

Bilateral renal lymphoma: rapid recovery from an acute kidney injury after open renal biopsy.

Mitome T, Furuya K, Imano M, Osaka K, Yokomizo Y, Hayashi N, Nakaigawa N, Yamanaka S, Yao M.

Clin Case Rep. 2015 Oct 7;4(1):5-8. doi: 10.1002/ccr3.401. eCollection 2016 Jan.

27.

Impact of Accidental Tumor Incision During Laparoscopic Partial Nephrectomy on the Oncologic and Clinical Outcomes.

Ito H, Makiyama K, Kawahara T, Osaka K, Izumi K, Yokomizo Y, Nakaigawa N, Yamanaka S, Yao M.

Clin Genitourin Cancer. 2016 Aug;14(4):e291-7. doi: 10.1016/j.clgc.2015.11.013. Epub 2015 Nov 26.

PMID:
26724862
28.

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.

Kawahara T, Fukui S, Sakamaki K, Ito Y, Ito H, Kobayashi N, Izumi K, Yokomizo Y, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Yao M, Miyamoto H, Uemura H.

Oncotarget. 2015 Oct 13;6(31):32169-76. doi: 10.18632/oncotarget.5081.

29.

Comparison of 12- and 16-core prostate biopsy in japanese patients with serum prostate-specific antigen level of 4.0-20.0 ng/mL.

Miyoshi Y, Furuya M, Teranishi J, Noguchi K, Uemura H, Yokomizo Y, Sugiura S, Kubota Y.

Urol J. 2014 Jul 8;11(3):1609-14.

30.
31.

Anemia affects the quality of life of Japanese cancer patients.

Wasada I, Eguchi H, Kurita M, Kudo S, Shishida T, Mishima Y, Saito Y, Ushiorozawa N, Seto T, Shimozuma K, Morita S, Saito M, Yokomizo Y, Ishizawa K, Ohashi Y, Eguchi K.

Tokai J Exp Clin Med. 2013 Apr 20;38(1):7-11.

32.

Urinary tract management in patients with incomplete cervical cord injury during the recovery phase.

Gohbara A, Tanaka K, Kawaji K, Yokomizo Y.

Spinal Cord. 2013 Apr;51(4):310-3. doi: 10.1038/sc.2012.138. Epub 2012 Nov 27.

PMID:
23184025
33.

Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial.

Oizumi S, Kobayashi K, Inoue A, Maemondo M, Sugawara S, Yoshizawa H, Isobe H, Harada M, Kinoshita I, Okinaga S, Kato T, Harada T, Gemma A, Saijo Y, Yokomizo Y, Morita S, Hagiwara K, Nukiwa T.

Oncologist. 2012;17(6):863-70. doi: 10.1634/theoncologist.2011-0426. Epub 2012 May 11.

34.

Effect of a single intrauterine administration of recombinant bovine interferon-τ on day 7 of the estrous cycle on the luteal phase length and blood profile in dairy cows.

Matsunaga S, Osawa T, Geshi M, Takahashi H, Inumaru S, Yokomizo Y, Miyake YI.

Res Vet Sci. 2012 Aug;93(1):381-5. doi: 10.1016/j.rvsc.2011.05.006. Epub 2011 Jun 8.

PMID:
21652051
35.

Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors.

Yoshikawa K, Yoshino T, Yokomizo Y, Uoto K, Naito H, Kawakami K, Mochizuki A, Nagata T, Suzuki M, Kanno H, Takemura M, Ohta T.

Bioorg Med Chem Lett. 2011 Apr 1;21(7):2133-40. doi: 10.1016/j.bmcl.2011.01.132. Epub 2011 Feb 1.

PMID:
21345673
36.

[A case of cerebellar hemorrhage secondary to autonomic dysreflexia (AD) in a patient with cervical spinal cord injury].

Yokomizo Y, Goubara A, Tanaka K, Yokoyama O.

Hinyokika Kiyo. 2010 Nov;56(11):659-61. Japanese.

37.

[Two cases of pellagra associated with chemotherapy of docetaxel, estramustine, dexamethasone].

Yokomizo Y, Fujikawa A, Tajiri T, Ota J, Yumura Y, Moriyama M, Mouri S.

Hinyokika Kiyo. 2010 Oct;56(10):585-8. Japanese.

38.

[A clinical study for intravesical recurrence after surgical therapy of urotherial carcinoma of the upper urinary tract].

Yumura Y, Oota J, Fujikawa A, Tajiri T, Kawai M, Yokomizo Y, Moriyama M, Kobayashi K, Noguchi S, Fujinami K, Senga Y.

Hinyokika Kiyo. 2010 Jul;56(7):355-9. Japanese.

39.

Clinical features of epilepsy with pervasive developmental disorder.

Kurokawa T, Yokomizo Y, Lee S, Kusuda T.

Brain Dev. 2010 Oct;32(9):764-8. doi: 10.1016/j.braindev.2010.05.008. Epub 2010 Aug 13.

PMID:
20708864
40.

[Low-dose docetaxel, estramustine and dexamethasone combination chemotherapy for hormone-refractory prostate cancer].

Kobayashi K, Yokonishi T, Ito Y, Matsumoto T, Umemoto S, Osaka K, Nakamura M, Onuki T, Komiya A, Ohgo Y, Sakai N, Noguchi S, Kishi H, Yokomizo Y, Kawai M, Okajima K, Tajiri T, Fujikawa A, Ohta J, Yumura Y, Moriyama M.

Hinyokika Kiyo. 2010 Apr;56(4):203-7. Japanese.

41.

[A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate].

Tanaka Y, Koga M, Yokomizo Y, Inokuchi S, Koga C, Kusukawa J.

Gan To Kagaku Ryoho. 2010 Apr;37(4):681-5. Japanese.

PMID:
20414026
42.

[The relationship between inflammatory bowel disease (IBD) and complications of urinary and male genital tracts].

Yumura Y, Oota J, Fujikawa A, Yokomizo Y, Moriyama M.

Hinyokika Kiyo. 2009 Nov;55(11):677-83. Japanese.

43.

Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.

Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.

Urol Int. 2009;82(3):280-5. doi: 10.1159/000209358. Epub 2009 May 11.

PMID:
19440014
44.

[A clinical study concerning survival of operative cases for the transitional cell carcinoma of the upper urinary tract].

Yumura Y, Fujikawa A, Tajiri T, Kawai M, Yokomizo Y, Moriyama M, Noguchi S, Ogo Y, Kobayashi K, Senga Y, Fujinami K, Yamashita Y, Okajima K.

Hinyokika Kiyo. 2009 Feb;55(2):65-70. Japanese.

45.
46.

Activation of immune cells in bovine mammary gland secretions by zymosan-treated bovine serum.

Kimura K, Goff JP, Schmerr MJ, Stabel JR, Inumaru S, Yokomizo Y.

J Dairy Sci. 2008 May;91(5):1852-64. doi: 10.3168/jds.2007-0895.

47.

Cross-cultural validation of the Japanese version of the lung cancer subscale on the functional assessment of cancer therapy-lung.

Saitoh E, Yokomizo Y, Chang CH, Eremenco S, Kaneko H, Kobayashi K.

J Nippon Med Sch. 2007 Dec;74(6):402-8.

48.

[Neoadjuvant and adjuvant chemotherapy with methotrexate, cisplatin and bleomycin for advanced penile cancer: a case report].

Yumura Y, Takase K, Suwa H, Ohta J, Ueki T, Kawai M, Fujikawa A, Yokomizo Y, Moriyama M.

Hinyokika Kiyo. 2007 Nov;53(11):825-7. Japanese.

49.

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.

Yoshida K, Nakayama K, Ohtsuka M, Kuru N, Yokomizo Y, Sakamoto A, Takemura M, Hoshino K, Kanda H, Nitanai H, Namba K, Yoshida K, Imamura Y, Zhang JZ, Lee VJ, Watkins WJ.

Bioorg Med Chem. 2007 Nov 15;15(22):7087-97. Epub 2007 Aug 22.

PMID:
17869116
50.

Development of efficient method for purified recombinant bovine granulocyte-macrophage colony-stimulating factor production with baculovirus-silkworm gene expression system.

Nagaya H, Kanaya T, Tobita Y, Yokomizo Y, Inumaru S, Onodera T.

Biotechnol Lett. 2008 Jan;30(1):41-5. Epub 2007 Aug 14.

PMID:
17700995

Supplemental Content

Loading ...
Support Center